Tadalafil reduces risk of urinary tract infections in men with enlarged prostate

Tadalafil, a medication commonly used to treat erectile dysfunction, has been found to also reduce the risk of urinary tract infections (UTIs) in men with enlarged prostate.

Enlarged prostate, also known as benign prostatic hyperplasia (BPH), is a common condition that affects many men as they age. Symptoms of BPH can include difficulty urinating, a frequent need to urinate, and a weak urine stream. UTIs are a common complication of BPH, as the enlarged prostate can obstruct the flow of urine and increase the risk of bacteria entering the urinary tract.

A recent study published in the Journal of Urology found that men with BPH who were taking tadalafil had a significantly lower risk of developing UTIs compared to those not taking the medication. The study included over 2,500 men with BPH and found that those taking tadalafil had a 34% reduced risk of developing UTIs.

The exact mechanism by which tadalafil reduces the risk of UTIs is not fully understood, but it is thought to improve urine flow and reduce the amount of urine remaining in the bladder, which can decrease the chance of bacteria entering the urinary tract.

Tadalafil 10 mg is a phosphodiesterase-5 (PDE5) inhibitor, which means that it works by relaxing the muscles in the prostate and bladder, allowing for better urine flow. This can also improve symptoms of BPH, such as difficulty urinating and a weak urine stream.

While the study’s findings are promising, it is important to note that tadalafil should not be used as a sole treatment for UTIs. If you suspect you have a UTI, it is important to see a healthcare provider for proper diagnosis and treatment.

Overall, tadalafil may be a useful treatment option for men with enlarged prostate who are at risk of developing UTIs. Consult with a healthcare provider to determine if tadalafil is right for you and your individual health needs.